Kim JR - Search Results

1

Inhibition of histone deacetylase activity down-regulates urokinase plasminogen activator and matrix metalloproteinase-9 expression in gastric cancer.

Lee KH, Choi EY, Kim MK, Kim KO, Jang BI, Kim SW, Kim SW, Song SK, Kim JR. Lee KH, et al. Among authors: kim ko, kim sw, kim jr, kim mk. Mol Cell Biochem. 2010 Oct;343(1-2):163-71. doi: 10.1007/s11010-010-0510-x. Epub 2010 Jun 18. Mol Cell Biochem. 2010. PMID: 20559690

2

Growth factor-dependent activation of the MAPK pathway in human pancreatic cancer: MEK/ERK and p38 MAP kinase interaction in uPA synthesis.

Lee KH, Hyun MS, Kim JR. Lee KH, et al. Among authors: kim jr. Clin Exp Metastasis. 2003;20(6):499-505. doi: 10.1023/a:1025824816021. Clin Exp Metastasis. 2003. PMID: 14598883

3

Identification of amyloid beta-peptide responsive genes by cDNA microarray technology: involvement of RTP801 in amyloid beta-peptide toxicity.

Kim JR, Lee SR, Chung HJ, Kim S, Baek SH, Kim JH, Kim YS. Kim JR, et al. Among authors: kim s, kim ys, kim jh. Exp Mol Med. 2003 Oct 31;35(5):403-11. doi: 10.1038/emm.2003.53. Exp Mol Med. 2003. PMID: 14646594

4

Involvement of MAPK pathway in hypoxia-induced up-regulation of urokinase plasminogen activator receptor in a human prostatic cancer cell line, PC3MLN4.

Lee KH, Choi EY, Hyun MS, Kim JR. Lee KH, et al. Among authors: kim jr. Exp Mol Med. 2004 Feb 29;36(1):57-64. doi: 10.1038/emm.2004.8. Exp Mol Med. 2004. PMID: 15031672

5

Regulation of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MEK/ERK activation in human stomach cancer cell lines.

Lee KH, Choi EY, Kim MK, Hyun MS, Jang BI, Kim TN, Kim SW, Song SK, Kim JH, Kim JR. Lee KH, et al. Among authors: kim sw, kim jr, kim tn, kim mk, kim jh. Exp Mol Med. 2006 Feb 28;38(1):27-35. doi: 10.1038/emm.2006.4. Exp Mol Med. 2006. PMID: 16520550

6

Hepatocyte growth factor/c-met signaling in regulating urokinase plasminogen activator in human stomach cancer: A potential therapeutic target for human stomach cancer.

Lee KH, Choi EY, Hyun MS, Jang BI, Kim TN, Kim SW, Song SK, Kim JH, Kim JR. Lee KH, et al. Among authors: kim sw, kim jr, kim tn, kim jh. Korean J Intern Med. 2006 Mar;21(1):20-7. doi: 10.3904/kjim.2006.21.1.20. Korean J Intern Med. 2006. PMID: 16646560 Free PMC article.

7

Association of anti-obesity activity of N-acetylcysteine with metallothionein-II down-regulation.

Kim JR, Ryu HH, Chung HJ, Lee JH, Kim SW, Kwun WH, Baek SH, Kim JH. Kim JR, et al. Among authors: kim sw, kim jh. Exp Mol Med. 2006 Apr 30;38(2):162-72. doi: 10.1038/emm.2006.20. Exp Mol Med. 2006. PMID: 16672770

8

Activation of toll-like receptor-9 induces matrix metalloproteinase-9 expression through Akt and tumor necrosis factor-alpha signaling.

Lim EJ, Lee SH, Lee JG, Chin BR, Bae YS, Kim JR, Lee CH, Baek SH. Lim EJ, et al. Among authors: kim jr. FEBS Lett. 2006 Aug 7;580(18):4533-8. doi: 10.1016/j.febslet.2006.06.100. Epub 2006 Jul 17. FEBS Lett. 2006. PMID: 16870179 Free article.

9

Phosphatidic acid as a regulator of matrix metalloproteinase-9 expression via the TNF-alpha signaling pathway.

Lee JG, Lee SH, Park DW, Bae YS, Yun SS, Kim JR, Baek SH. Lee JG, et al. Among authors: kim jr. FEBS Lett. 2007 Feb 20;581(4):787-93. doi: 10.1016/j.febslet.2007.01.048. Epub 2007 Jan 30. FEBS Lett. 2007. PMID: 17276429 Free article.

10

Toll-like receptor 9 dependent activation of MAPK and NF-kB is required for the CpG ODN-induced matrix metalloproteinase-9 expression.

Lim EJ, Lee SH, Lee JG, Kim JR, Yun SS, Baek SH, Lee C. Lim EJ, et al. Among authors: kim jr. Exp Mol Med. 2007 Apr 30;39(2):239-45. doi: 10.1038/emm.2007.27. Exp Mol Med. 2007. PMID: 17464186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,150 results

Search Page

Filters